Pilot study of the combination of capecitabine plus oxaliplatin as adjuvant therapy for patients with stage III and high risk stage II colon cancer

被引：0
|
作者：
Olier, C. [1 ]
Reyna, C. [1 ]
Aramendia, J. M. [1 ]
Rodriguez, J. [1 ]
Viudez, A. [1 ]
Chopitea, A. [1 ]
Garcia-Foncillas, J. [1 ]
机构：
[1] Univ Navarra Clin, Pamplona, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.15093
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
15093
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Adjuvant 5-Fluorouracil/leucovorin, capecitabine, and oxaliplatin-related regimens for stage II/III colon cancer patients 66 years or older
    Jones, Emily
    Duan, Zhigang
    Nguyen, Thinh T.
    Giordano, Sharon H.
    Zhao, Hui
    CANCER MEDICINE, 2023, 12 (03): : 2389 - 2406
  • [32] The efficacy of oxaliplatin combination adjuvant chemotherapy for elderly patients with stage III colorectal cancer
    Hayashi, Naomi
    Kanda, Mitsuro
    Omae, Kenji
    Kodera, Yasuhiro
    NAGOYA JOURNAL OF MEDICAL SCIENCE, 2020, 82 (04): : 603 - 611
  • [33] Adjuvant therapy for stage II and III colon cancer in elderly patients: NCDB analysis.
    Master, Samip R.
    Shi, Lawrence
    Shah, Chintan
    Shi, Runhua
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [34] Toxicity of Oxaliplatin Plus Fluorouracil/Leucovorin Adjuvant Chemotherapy in Elderly Patients with Stage III Colon Cancer: A Population-Based Study
    Hamza, Samia
    Bouvier, Anne-Marie
    Rollot, Fabien
    Lepage, Come
    Faivre, Jean
    Bedenne, Laurent
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 (08) : 2636 - 2641
  • [35] Toxicity of Oxaliplatin Plus Fluorouracil/Leucovorin Adjuvant Chemotherapy in Elderly Patients with Stage III Colon Cancer: A Population-Based Study
    Samia Hamza
    Anne-Marie Bouvier
    Fabien Rollot
    Côme Lepage
    Jean Faivre
    Laurent Bedenne
    Annals of Surgical Oncology, 2014, 21 : 2636 - 2641
  • [36] Adjuvant therapy in patients with stage II and III colon cancer under 70 years of age
    Dumont, Sarah N.
    Chibaudel, Benoist
    Bengrine-Lefevre, Leila
    Andre, Thierry
    de Gramont, Aimery
    COLORECTAL CANCER, 2013, 2 (03) : 205 - 217
  • [37] Adjuvant therapy report card: Patients with stage II/III colon cancer grade their oncologists
    Love, N.
    Ziel, K. Ault
    Bylund, C.
    Elder, M.
    Ellis, L. M.
    Grothey, A.
    Meropol, N. J.
    Paley, D.
    Ravdin, P. M.
    Saltz, L. B.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [38] Adjuvant chemotherapy for high-risk stage II and stage III colon cancer: timing of initiation and optimal duration
    Cruz, Jan Paolo M.
    Pales, Chris George C.
    Kim, Kwang Min
    Kim, Young Wan
    JOURNAL OF BUON, 2018, 23 (03): : 568 - 573
  • [39] Adjuvant capecitabine treatment for stage III colon cancer in Japanese patients (KSCC0803)
    Kitazono, M.
    Emi, Y.
    Kakeji, Y.
    Sakaguchi, Y.
    Samura, H.
    Ogata, Y.
    Natsugoe, S.
    Shirouzu, K.
    Tokunaga, S.
    Maehara, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [40] Clinical classification-based evaluation of adjuvant therapy with oxaliplatin in stage II colon cancer
    Chibaudel, B.
    Raeisi, M.
    Andre, T.
    Yothers, G.
    Schmoll, H.
    Bachet, J.
    Cohen, R.
    Wolmark, N.
    Yoshino, T.
    Goldberg, R.
    Kerr, R.
    Lonardi, S.
    George, T.
    Shacham-Shmueli, E.
    Sharara, L.
    Shi, Q.
    de Gramont, A.
    ANNALS OF ONCOLOGY, 2022, 33 : S366 - S367
12345